DocSym
β
Searchsearch
Search
(B46.0) Pulmonary mucormycosis
More details coming soon
1 727 in individuals diagnosis pulmonary mucormycosis confirmed
2 784 deaths with diagnosis pulmonary mucormycosis
161% mortality rate associated with the disease pulmonary mucormycosis
Diagnosis pulmonary mucormycosis is diagnosed Men are 28.20% more likely than Women
1 107
Men receive the diagnosis pulmonary mucormycosis
2 068 (186.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
620
Women receive the diagnosis pulmonary mucormycosis
716 (115.5 %)Died from this diagnosis.
Risk Group for the Disease pulmonary mucormycosis - Men aged 15-19 and Women aged 65-69
In Men diagnosis is most often set at age 15-19, 35-39, 50-59
Less common in men the disease occurs at Age 0-14, 20-34, 40-49, 60-95+Less common in women the disease occurs at Age 0-64, 70-95+
In Women diagnosis is most often set at age 65-69
Disease Features pulmonary mucormycosis
Absence or low individual and public risk
Pulmonary mucormycosis - what does this mean
Pulmonary mucormycosis is a rare fungal infection that occurs when a person inhales fungal spores from the environment. it is more common in people with weakened immune systems or who have diabetes, and can cause severe chest pain, coughing, and difficulty breathing. if left untreated, it can spread to other organs and cause serious complications.
What happens during the disease - pulmonary mucormycosis
Pulmonary mucormycosis is an infection caused by a group of fungi known as mucormycetes. it is a rare but serious infection that typically occurs in people with weakened immune systems, such as those with uncontrolled diabetes, cancer, or organ transplant recipients. it is thought to occur when the fungi enter the lungs through inhalation of contaminated dust particles or spores. once inhaled, the fungi can invade the lungs and spread to other organs, leading to serious tissue damage and potentially fatal complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Chest X-ray
- CT scan
- Bronchoscopy with BAL
- Sputum culture
- Biopsy of the affected tissue
- Serum and urine tests
- Blood cultures
- Lung function tests
Treatment and Medical Assistance
Main goal of the treatment:
To reduce the spread of the infection, reduce the severity of symptoms, and improve overall health.
- Prescribing antifungal medications
- Administering oxygen therapy
- Surgery to remove infected tissue
- Removing any foreign objects from the lungs
- Providing supportive care to reduce symptoms
- Monitoring the patient’s condition and adjusting treatment as needed
38 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Pulmonary mucormycosis - Prevention
Pulmonary mucormycosis can be prevented by avoiding contact with areas contaminated with mold, wearing a mask when working with soil, compost, or other organic material, and taking measures to reduce the risk of inhalation of airborne spores. additionally, individuals with weakened immune systems should take extra precautions, such as avoiding contact with soil and compost, and wearing a mask when working with organic material.